Alpha 2.0
Login Register
» Articles » PMID: 11345947

An Open Trial of Risperidone Augmentation of Partial Response to Clozapine

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2001 May 11
PMID 11345947
Citations 11
Authors
C G Taylor
S W Flynn
S Altman
T Ehmann
G W MacEwan
W G Honer
Affiliations
Soon will be listed here.
Citing Articles

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome.

Jeon S, Kim Y Int J Mol Sci. 2017; 18(10).

PMID: 29057817 PMC: 5666855. DOI: 10.3390/ijms18102174.

Efficacy and clinical determinants of antipsychotic polypharmacy in psychotic patients experiencing an acute relapse and admitted to hospital stay: results from a cross-sectional and a subsequent longitudinal pilot study.

Iasevoli F, Buonaguro E, Marconi M, Di Giovambattista E, Rapagnani M, de Berardis D ISRN Pharmacol. 2014; 2014:762127.

PMID: 24592333 PMC: 3921985. DOI: 10.1155/2014/762127.

Antipsychotics prescribing patterns of patients with schizophrenia admitted to korean general hospital psychiatric unit: 2001 to 2008.

Choi H, Jung S, Kang M, Lee J, Bae J, Kim C Clin Psychopharmacol Neurosci. 2013; 9(1):17-22.

PMID: 23430568 PMC: 3568650. DOI: 10.9758/cpn.2011.9.1.17.

Treatment-refractory schizophrenia.

Caspi A, Davidson M, Tamminga C Dialogues Clin Neurosci. 2011; 6(1):61-70.

PMID: 22034144 PMC: 3181784.

Concept and Management of Treatment Resistant Schizophrenia (TRS).

Painuly N, Gupta N, Avasthi A Indian J Psychiatry. 2011; 46(2):125-34.

PMID: 21408038 PMC: 2949927.